Accessibility Menu
Xencor logo

Xencor

(NASDAQ) XNCR

Current Price$14.03
Market Cap$1.04B
Since IPO (2013)+68%
5 Year-62%
1 Year+64%
1 Month+24%

Xencor Financials at a Glance

Market Cap

$1.04B

Revenue (TTM)

$97.36M

Net Income (TTM)

-$172.42M

EPS (TTM)

-$2.30

P/E Ratio

-6.10

Dividend

$0.00

Beta (Volatility)

1.20 (Average)

Price

$14.03

Volume

868

Open

$12.89

Previous Close

$14.01

Daily Range

$12.89 - $14.21

52-Week Range

$6.92 - $18.69

Estimated Earnings Date

Aug 5, 2026

XNCR: Motley Fool Moneyball Superscore

58

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Xencor

Industry

Biotechnology

Employees

260

CEO

Bassil I. Dahiyat, PhD

Headquarters

Pasadena, CA 91016, US

XNCR Financials

Key Financial Metrics (TTM)

Gross Margin

36%

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

-30%

Return on Capital

-32%

Return on Assets

-23%

Earnings Yield

-16.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.04B

Shares Outstanding

74.14M

Volume

868

Avg. Volume

804.91K

Financials (TTM)

Gross Profit

$115.06M

Operating Income

-$177.50M

EBITDA

-$46.98M

Operating Cash Flow

-$135.12M

Capital Expenditure

-$3.15M

Free Cash Flow

-$138.27M

Cash & ST Invst.

$547.73M

Total Debt

$187.75M

Xencor Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$4.52M

-86.2%

Gross Profit

$1.95M

-93.5%

Gross Margin

43.16%

N/A

Market Cap

$1.04B

N/A

Market Cap/Employee

$4.15M

N/A

Employees

250

N/A

Net Income

-$128.92M

-166.3%

EBITDA

-$121.37M

-228.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$444.95M

-5.2%

Total Debt

$175.16M

+158.3%

Accounts Receivable

$12.00M

-68.2%

Inventory

$0.00

N/A

Long Term Debt

$144.72M

+125.5%

Short Term Debt

$30.44M

+736.4%

Return on Assets

-23.40%

N/A

Return on Invested Capital

-31.98%

N/A

Free Cash Flow

-$68.24M

-286.3%

Operating Cash Flow

-$67.63M

-316.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PHATPhathom Pharmaceuticals, Inc.
$10.69-1.75%
NKTRNektar Therapeutics
$65.70+7.74%
OCSOculis Holding AG
$11.67+4.01%
BBOTBridgeBio Oncology Therapeutics Inc.
$7.87+4.10%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$36.93+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$82.58-0.00%
NOKNokia
$14.43+0.07%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.37+0.02%

Questions About XNCR

What is the current price of Xencor?

Xencor is trading at $14.01 per share.

What is the 52-week range for Xencor?

Over the past 52 weeks, Xencor has traded between $6.92 and $18.69.

How much debt does Xencor have?

As of the most recent reporting period, Xencor reported total debt of $175.16M.

How much cash does Xencor have on hand?

Xencor reported $14.17M in cash and cash equivalents in its most recent financial results.

What is Xencor’s dividend yield?

Xencor does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.